Sarcoidosis is a multi-system disease with a wide range of
phenotypes. Pulmonary involvement is the most frequently
identified target for sarcoidosis and is responsible for
the majority of deaths. Cardiac sarcoid is less commonly
identified, may be occult, is significantly influenced by race,
and can portend an unpredictable and sometimes fatal
outcome. Sarcoidosis remains an enigmatic disease spectrum
of unknown aetiology, frequently difficult to diagnose and
with a variable disease course. This article summarises current
views on the diagnosis and management of cardiopulmonary
involvement.